Diabetic metastatic castration resistant prostate cancer patients administered mefformin during docetaxel chemotherapy have improved prostate cancer-specific and overall survival

被引：1
|
作者：
Mayer, Michelle
Klotz, Laurence
Venkateswaran, Vasundara
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1434
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1434
引用
收藏
页数：4
相关论文
共 50 条
  • [1] The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer
    Mayer, Michelle J.
    Klotz, Laurence H.
    Venkateswaran, Vasundara
    JOURNAL OF UROLOGY, 2017, 197 (04): : 1068 - 1074
  • [2] Re: The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer
    Ozgur, Berat Cem
    JOURNAL OF UROLOGY, 2018, 199 (05): : 1355 - 1356
  • [3] The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer EDITORIAL COMMENTS
    Preston, Mark A.
    JOURNAL OF UROLOGY, 2017, 197 (04): : 1075 - 1075
  • [4] Re: The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer Reply
    不详
    JOURNAL OF UROLOGY, 2018, 199 (05): : 1356 - 1356
  • [5] Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel
    Ryan, Charles J.
    Dutta, Sandipan
    Kelly, William K.
    Middleberg, Rob
    Russell, Carly
    Morris, Michael J.
    Taplin, Mary-Ellen
    Halabi, Susan
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 222 - +
  • [6] Improvement in overall and cancer-specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients
    Hoeh, Benedikt
    Wuernschimmel, Christoph
    Flammia, Rocco S.
    Horlemann, Benedikt
    Sorce, Gabriele
    Chierigo, Francesco
    Tian, Zhe
    Saad, Fred
    Graefen, Markus
    Gallucci, Michele
    Briganti, Alberto
    Terrone, Carlo
    Shariat, Shahrokh F.
    Tilki, Derya
    Kluth, Luis A.
    Mandel, Philipp
    Chun, Felix K. H.
    Karakiewicz, Pierre, I
    PROSTATE, 2021, 81 (16): : 1374 - 1381
  • [7] Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer
    Miao, Qi
    Wei, Zhihao
    Liu, Chenchen
    Ye, Yuzhong
    Cheng, Gong
    Song, Zhengshuai
    Chen, Kailei
    Zhang, Yunxuan
    Chen, Jiawei
    Yue, Changjie
    Ruan, Hailong
    Zhang, Xiaoping
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] Predictors of overall survival in patients with metastatic castration-resistant prostate cancer
    Markova, A. S.
    Polikarpova, S. B.
    Kamolov, B. Sh.
    Gridneva, Ya. V.
    Kalinin, S. A.
    Peters, M. V.
    Matveev, V. B.
    ONKOUROLOGIYA, 2015, 11 (02): : 77 - 84
  • [9] Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel
    Halabi, Susan
    Dutta, Sandipan
    Tangen, Catherine M.
    Rosenthal, Mark
    Petrylak, Daniel P.
    Thompson, Ian M.
    Chi, Kim N.
    Araujo, John C.
    Logothetis, Christopher
    Quinn, David I.
    Fizazi, Karim
    Morris, Michael J.
    Eisenberger, Mario A.
    George, Daniel J.
    De Bono, Johann S.
    Higano, Celestia S.
    Tannock, Ian F.
    Small, Eric J.
    Kelly, William Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (05) : 403 - +
  • [10] Chemotherapy in metastatic castration resistant prostate cancer
    Rosino, Antonio
    Ballester, Inmaculada
    Tudela, Julian
    Gonzalez-Billalabeitia, Enrique
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (08): : 676 - 684
12345